Stanley Prince | CCO
PathoQuest

Stanley has over 20 years of experience in vaccine development, biologics, and cell/gene therapy, with a strong background in GMP biosafety, GLP technical operations, and commercial strategy. He holds a Bachelor of Science from Pennsylvania State University and an MBA from Alvernia University. 
His career has spanned roles in laboratory operations, project management, and commercial leadership within contract research organizations. For the past 12 years, Stanley has been actively involved in Next-Generation Sequencing (NGS) as part of biosafety programs.